Resultados: 4

    European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma

    Eur. respir. j; 62 (), 2023
    Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formoterol have provided new evidence that may warrant a reconsideration of current practice. A Task Force was set up by the European Respiratory Society to provide evidence-based recommendations on the use of as-n...

    Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

    Eur. respir. j; 57 (4), 2021
    Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of SARS-CoV-2 infection have a high mortality rate and frequently require noninvasive respiratory support or invasive ventilation. Optimising and standardising management through evidence-based guidelines may improve quality of ca...

    Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline

    Eur. respir. j; 54 (3), 2019
    This document provides clinical recommendations for the management of severe asthma. Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions. The evidence was appraised using the Grading of Recommendations, Asses...

    European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia

    Eur. respir. j; 54 (3), 2019
    This document provides recommendations for monitoring and treatment of children in whom bronchopulmonary dysplasia (BPD) has been established and were discharged from the hospital, or who were older than 36 weeks of postmenstrual age. The guideline was based on pre-defined Population, Intervention, Com...